Page 42 - Annual Report
P. 42

Council and Committee Reports 院務委員會及其他委員會報告

            Task Force on Artificial Intelligence                         人工智能專責小組
            Launch of HKAM AI Portal                                      醫專人工智能平台

            Led by the Task Force on Artificial Intelligence (AI), and with   在香港大學李嘉誠醫學院教育科技團
            support from the Education  Technology and Student in         隊及香港大學醫學倫理與法律研究中
            Medical and Health Sciences Education (EdTech & SIMHSE)       心的支持下,委員會轄下的人工智能專
            team of the Hong Kong University (HKU) LKS Faculty of         責小組於2024年10月推出「醫專人工智
            Medicine (HKUMed) and the Centre for Medical Ethics and       能平台」,旨在分享人工智能在醫學領
            Law (CMEL) of HKU in sharing the valuable resources, the      域的發展以及與醫學專業、道德倫理及
            HKAM  AI Portal was successfully launched in October 2024     法律相關的資源和培訓。作為專為人工
            to share resources and training materials on developments,    智能而設的平台,院士們及其他醫療人
            professionalism, ethical and legal aspects of  Artificial     員可以從此獲取多項有關的多媒體資
            Intelligence (AI) in healthcare.  This portal aims to serve as   源,包括醫專舉辦與人工智能相關研討
            a resource platform for use by  Academy Fellows and other     會的錄影、人工智能相關文獻、研討會
            healthcare  professionals. Multi-media content such  as  event   回顧、以及人工智能教材及指引等。
            recordings of AI-focused seminars and webinars organised by
            the Academy, AI-related reading materials, conference review,
            teaching materials and guidelines on AI etc. are available in the
            Portal.

            Task Force on Genetics and Genomics                           遺傳學及基因組學專責小組
            HKAM-HKGI Research Excellence Grants in Genomic               香港醫學專科學院-香港基因組中心
            Medicine 2024                                                 基因組醫學卓越研究獎2024

            The HKAM-HKGI Research Excellence Grants in Genomic           由醫專與香港基因組中心共同設立的
            Medicine (the Grant) is jointly introduced by the Academy and   香港醫學專科學院-香港基因組中心
            Hong Kong Genome Institute (HKGI). It aims to encourage       基因組醫學卓越研究獎旨在鼓勵和支
            and support initiatives of research in the field of genetic and   持年青院士和高級專科培訓學員開展
            genomic medicine conducted by the Academy’s young Fellows     基因組醫學相關研究。首輪研究獎已於
            and higher specialist trainees. Further to the successful launch   2023年頒發予三名得獎者。第二輪研究
            of the first round of the Grant in 2023, the second round of   獎於2024年7月開放申請,截止日期前
            the Grant was opened in July 2024. Five applications were     共收到五份申請。經評審後,三名年青
            received by the deadline. After due assessment, three young   院士獲得獎項。詳情如下:
            Fellows were awarded the Grant. Details are as follows:


             Awardee (Specialty)                                Project Title
             得獎者(分科)                                            項目標題
             Prof. Chan Yu Hin (Paediatrics)                    Unraveling the disease pathogenesis of childhood

             陳宇軒教授(兒科)                                          steroid-resistant nephrotic syndrome through
                                                                spatially resolved transcriptome signatures of
                                                                kidney tissue
             Dr. Wong Siu Him Janus (Orthopaedic Surgery)       Identification of genomic risk factors of atypical
             黃兆謙醫生(骨科)                                          femoral fracture through whole genome
                                                                sequencing and development of fracture risk
                                                                assessment tool – a multicentre study

             Dr. Ma Mingyao (Medicine)                          Personalize drug prescription in kidney transplant
             馬銘遙醫生(內科)                                          recipients  utilizing pharmacogenetics panel –  an
                                                                exploratory prospective, randomized controlled
                                                                clinical trial





     40          HKAM Annual Report 2025
   37   38   39   40   41   42   43   44   45   46   47